Laddar...
Allogeneic CAR-T Cells: More than Ease of Access?
Patient derived anti-CD19 chimeric antigen receptor-T (CAR-T) cells are a powerful tool in achieving a complete remission in a range of B-cell malignancies, most notably B-acute lymphoblastic leukaemia (B-ALL) and diffuse large B-cell lymphoma (DLBCL). However, there are limitations, including inabi...
Sparad:
| I publikationen: | Cells |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
MDPI
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6210057/ https://ncbi.nlm.nih.gov/pubmed/30275435 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells7100155 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|